|
Thioridazine Hydrochloride Oral Solution
DEFINITION
Thioridazine Hydrochloride Oral Solution contains NLT 90.0% and NMT 110.0% of the labeled amount of thioridazine hydrochloride (C21H26N2S2·HCl).
[NoteThroughout the following procedures, protect samples, the Reference Standard, and the solutions containing them by conducting the procedures without delay, under subdued light, or by using low-actinic glassware. ]
IDENTIFICATION
• A. IdentificationOrganic Nitrogenous Bases
Sample solution:
2 mg/mL of thioridazine hydrochloride from a volume of Oral Solution in water. [NoteUse 2 mL of sodium bicarbonate solution (1 in 12) in place of the 2 mL of 1 N sodium hydroxide specified in the test. ]
Acceptance criteria:
Meets the requirements
ASSAY
[NoteConduct this procedure with minimum exposure to light. ]
• Procedure
Diluent:
Shake 125 mL of chloroform with 5 mL of ammonium hydroxide in a separator, slowly filter the bottom layer through filter paper containing anhydrous sodium sulfate, and discard the top layer.
Standard solution:
6 µg/mL of USP Thioridazine Hydrochloride RS in Diluent
Sample stock solution:
Nominal concentration of 0.6 mg/mL in chloroform prepared as follows: Pipet a portion of Oral Solution, equivalent to 120 mg of thioridazine hydrochloride, into a separator containing 15 mL of water. Render alkaline with ammonium hydroxide, and extract with three 25-mL portions of Diluent. Filter the extracts through a pledget of glass wool into a 200-mL volumetric flask. Rinse the filter, and add chloroform to volume.
Sample solution:
Nominally 6 µg/mL in Diluent from Sample stock solution
Instrumental conditions
Mode:
UV-Vis
Analytical wavelength:
265 nm
Cell:
1 cm
Blank:
Diluent
Analysis
Samples:
Standard solution, Sample solution, and Blank
Calculate the percentage of thioridazine hydrochloride (C21H26N2S2·HCl) in the portion of Oral Solution taken:
Result = (AU/AS) × (CS/CU) × 100
Acceptance criteria:
90.0%110.0%
OTHER COMPONENTS
• Alcohol Determination
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in tight, light-resistant containers, and store at controlled room temperature.
• Labeling:
Label it to indicate that it is to be diluted to appropriate strength with water or other suitable fluid prior to administration.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 4848
|